Gonococcal antimicrobial susceptibility surveillance in Europe 2009
Since 2009, the European Centre for Disease Prevention and Control has coordinated the enhanced surveillance of sexually transmitted infections in Europe. The goals of the STI surveillance network include strengthening the surveillance of gonococcal susceptibility in European Union/European Economic Area Member States, developing and implementing sentinel surveillance of antimicrobial resistant gonorrhoea to a range of therapeutically relevant antimicrobials and to implementing an external quality assurance scheme for gonococcal antimicrobial susceptibility testing across Europe are the focused aims of the network.
Euro-GASP external quality assessment scheme for Neisseria gonorrhoeae antimicrobial susceptibility testing - 2019
3 Dec 2021 - External quality assessment (EQA) is an essential part of any laboratory-based surveillance system, allowing for the monitoring of performance and comparability of results from participating laboratories, identification of potential issues and deployment of resources and training where necessary.
HIV/AIDS surveillance in Europe 2021 (2020 data)
30 Nov 2021 - This report is the latest in a series published jointly by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe that has been summarizing data on HIV and AIDS in the WHO European Region and in the European Union and European Economic Area (EU/EEA) since 2007.
Antimicrobial consumption in the EU/EEA (ESAC-Net) - Annual Epidemiological Report for 2020
18 Nov 2021 - For 2020, twenty-nine countries (27 European Union (EU) Member States and two European Economic Area (EEA) countries - Iceland and Norway) reported data on antimicrobial consumption. Twenty-five countries reported data for both community and hospital consumption; two countries (Germany and Iceland) reported only community consumption, and two countries (Cyprus and Czechia) reported total consumption for both sectors combined.